Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland.
Department of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
Biol Psychiatry. 2024 Nov 15;96(10):815-828. doi: 10.1016/j.biopsych.2023.12.020. Epub 2023 Dec 27.
Neuroligin-3 is a postsynaptic adhesion molecule involved in synapse development and function. It is implicated in rare, monogenic forms of autism, and its shedding is critical to the tumor microenvironment of gliomas. While other members of the neuroligin family exhibit synapse-type specificity in localization and function through distinct interactions with postsynaptic scaffold proteins, the specificity of neuroligin-3 synaptic localization remains largely unknown.
We investigated the synaptic localization of neuroligin-3 across regions in mouse and human brain samples after validating antibody specificity in knockout animals. We raised a phospho-specific neuroligin antibody and used phosphoproteomics, cell-based assays, and in utero CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/Cas9) knockout and gene replacement to identify mechanisms that regulate neuroligin-3 localization to distinct synapse types.
Neuroligin-3 exhibits region-dependent synapse specificity, largely localizing to excitatory synapses in cortical regions and inhibitory synapses in subcortical regions of the brain in both mice and humans. We identified specific phosphorylation of cortical neuroligin-3 at a key binding site for recruitment to inhibitory synapses, while subcortical neuroligin-3 remained unphosphorylated. In vitro, phosphomimetic mutation of that site disrupted neuroligin-3 association with the inhibitory postsynaptic scaffolding protein gephyrin. In vivo, phosphomimetic mutants of neuroligin-3 localized to excitatory postsynapses, while phospho-null mutants localized to inhibitory postsynapses.
These data reveal an unexpected region-specific pattern of neuroligin-3 synapse specificity, as well as a phosphorylation-dependent mechanism that regulates its recruitment to either excitatory or inhibitory synapses. These findings add to our understanding of how neuroligin-3 is involved in conditions that may affect the balance of excitation and inhibition.
神经黏连蛋白-3 是一种突触后黏附分子,参与突触的发育和功能。它与罕见的单基因形式的自闭症有关,其脱落对神经胶质瘤的肿瘤微环境至关重要。虽然神经黏连蛋白家族的其他成员通过与突触后支架蛋白的不同相互作用表现出在定位和功能上的突触类型特异性,但神经黏连蛋白-3 突触定位的特异性在很大程度上仍然未知。
我们在敲除动物中验证了抗体特异性后,研究了神经黏连蛋白-3 在小鼠和人类大脑样本中不同区域的突触定位。我们制备了一种磷酸化特异性神经黏连蛋白抗体,并利用磷酸化蛋白质组学、基于细胞的测定以及体内 CRISPR/Cas9(成簇规律间隔短回文重复序列/Cas9)敲除和基因替换来鉴定调节神经黏连蛋白-3 定位到不同突触类型的机制。
神经黏连蛋白-3 表现出区域依赖性的突触特异性,在小鼠和人类的皮质区域中主要定位于兴奋性突触,在皮质下区域中主要定位于抑制性突触。我们发现,皮质神经黏连蛋白-3 在一个关键的结合位点上发生特异性磷酸化,该位点对于招募到抑制性突触是必不可少的,而皮质下神经黏连蛋白-3 则保持非磷酸化状态。在体外,该位点的磷酸模拟突变破坏了神经黏连蛋白-3 与抑制性突触后支架蛋白神经胶质蛋白的结合。在体内,神经黏连蛋白-3 的磷酸模拟突变体定位于兴奋性突触后,而磷酸化缺失突变体则定位于抑制性突触后。
这些数据揭示了神经黏连蛋白-3 突触特异性的一种意想不到的区域特异性模式,以及一种依赖于磷酸化的机制,该机制调节其与兴奋性或抑制性突触的募集。这些发现增加了我们对神经黏连蛋白-3 如何参与可能影响兴奋和抑制平衡的条件的理解。